102 related articles for article (PubMed ID: 10602481)
61. Salt-inducible kinase 1 regulates E-cadherin expression and intercellular junction stability.
Eneling K; Brion L; Pinto V; Pinho MJ; Sznajder JI; Mochizuki N; Emoto K; Soares-da-Silva P; Bertorello AM
FASEB J; 2012 Aug; 26(8):3230-9. PubMed ID: 22522110
[TBL] [Abstract][Full Text] [Related]
62. SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis.
Byles V; Zhu L; Lovaas JD; Chmilewski LK; Wang J; Faller DV; Dai Y
Oncogene; 2012 Oct; 31(43):4619-29. PubMed ID: 22249256
[TBL] [Abstract][Full Text] [Related]
63. Cdc6 expression represses E-cadherin transcription and activates adjacent replication origins.
Sideridou M; Zakopoulou R; Evangelou K; Liontos M; Kotsinas A; Rampakakis E; Gagos S; Kahata K; Grabusic K; Gkouskou K; Trougakos IP; Kolettas E; Georgakilas AG; Volarevic S; Eliopoulos AG; Zannis-Hadjopoulos M; Moustakas A; Gorgoulis VG
J Cell Biol; 2011 Dec; 195(7):1123-40. PubMed ID: 22201124
[TBL] [Abstract][Full Text] [Related]
64. Interferon-β signaling contributes to Ras transformation.
Tsai YC; Pestka S; Wang LH; Runnels LW; Wan S; Lyu YL; Liu LF
PLoS One; 2011; 6(8):e24291. PubMed ID: 21897875
[TBL] [Abstract][Full Text] [Related]
65. BRG1 mutations found in human cancer cell lines inactivate Rb-mediated cell-cycle arrest.
Bartlett C; Orvis TJ; Rosson GS; Weissman BE
J Cell Physiol; 2011 Aug; 226(8):1989-97. PubMed ID: 21520050
[TBL] [Abstract][Full Text] [Related]
66. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer.
Guo BH; Feng Y; Zhang R; Xu LH; Li MZ; Kung HF; Song LB; Zeng MS
Mol Cancer; 2011 Jan; 10(1):10. PubMed ID: 21276221
[TBL] [Abstract][Full Text] [Related]
67. An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.
Yu J; Yu J; Mani RS; Cao Q; Brenner CJ; Cao X; Wang X; Wu L; Li J; Hu M; Gong Y; Cheng H; Laxman B; Vellaichamy A; Shankar S; Li Y; Dhanasekaran SM; Morey R; Barrette T; Lonigro RJ; Tomlins SA; Varambally S; Qin ZS; Chinnaiyan AM
Cancer Cell; 2010 May; 17(5):443-54. PubMed ID: 20478527
[TBL] [Abstract][Full Text] [Related]
68. Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast.
Prasad CP; Rath G; Mathur S; Bhatnagar D; Parshad R; Ralhan R
BMC Cancer; 2009 Sep; 9():325. PubMed ID: 19751508
[TBL] [Abstract][Full Text] [Related]
69. p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug.
Wang SP; Wang WL; Chang YL; Wu CT; Chao YC; Kao SH; Yuan A; Lin CW; Yang SC; Chan WK; Li KC; Hong TM; Yang PC
Nat Cell Biol; 2009 Jun; 11(6):694-704. PubMed ID: 19448627
[TBL] [Abstract][Full Text] [Related]
70. Restoration of E-cadherin cell-cell junctions requires both expression of E-cadherin and suppression of ERK MAP kinase activation in Ras-transformed breast epithelial cells.
Li Q; Mattingly RR
Neoplasia; 2008 Dec; 10(12):1444-58. PubMed ID: 19048123
[TBL] [Abstract][Full Text] [Related]
71. Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation.
Liao X; Siu MK; Au CW; Wong ES; Chan HY; Ip PP; Ngan HY; Cheung AN
Carcinogenesis; 2009 Jan; 30(1):131-40. PubMed ID: 19028702
[TBL] [Abstract][Full Text] [Related]
72. Repression of E-cadherin by the polycomb group protein EZH2 in cancer.
Cao Q; Yu J; Dhanasekaran SM; Kim JH; Mani RS; Tomlins SA; Mehra R; Laxman B; Cao X; Yu J; Kleer CG; Varambally S; Chinnaiyan AM
Oncogene; 2008 Dec; 27(58):7274-84. PubMed ID: 18806826
[TBL] [Abstract][Full Text] [Related]
73. New insights of epithelial-mesenchymal transition in cancer metastasis.
Wu Y; Zhou BP
Acta Biochim Biophys Sin (Shanghai); 2008 Jul; 40(7):643-50. PubMed ID: 18604456
[TBL] [Abstract][Full Text] [Related]
74. Inhibition of CCN6 (Wnt-1-induced signaling protein 3) down-regulates E-cadherin in the breast epithelium through induction of snail and ZEB1.
Huang W; Zhang Y; Varambally S; Chinnaiyan AM; Banerjee M; Merajver SD; Kleer CG
Am J Pathol; 2008 Apr; 172(4):893-904. PubMed ID: 18321996
[TBL] [Abstract][Full Text] [Related]
75. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
[TBL] [Abstract][Full Text] [Related]
76. Expression of E-cadherin and other paracellular junction genes is decreased in iron-loaded hepatocytes.
Bilello JP; Cable EE; Isom HC
Am J Pathol; 2003 Apr; 162(4):1323-38. PubMed ID: 12651624
[TBL] [Abstract][Full Text] [Related]
77. Genetic basis of human breast cancer metastasis.
Debies MT; Welch DR
J Mammary Gland Biol Neoplasia; 2001 Oct; 6(4):441-51. PubMed ID: 12013533
[TBL] [Abstract][Full Text] [Related]
78. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression.
Berx G; Van Roy F
Breast Cancer Res; 2001; 3(5):289-93. PubMed ID: 11597316
[TBL] [Abstract][Full Text] [Related]
79. Epigenetic gene silencing in cancer.
Tycko B
J Clin Invest; 2000 Feb; 105(4):401-7. PubMed ID: 10683367
[No Abstract] [Full Text] [Related]
80. Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements.
Hajra KM; Ji X; Fearon ER
Oncogene; 1999 Dec; 18(51):7274-9. PubMed ID: 10602481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
